Claude Cancés
Université Fédérale de Toulouse Midi-Pyrénées(FR)Centre Hospitalier Universitaire de Toulouse(FR)Hôpital Purpan(FR)Pharmacochimie et Pharmacologie pour le Développement(FR)Hôpital des Enfants(FR)
Publications by Year
Research Areas
Neurogenetic and Muscular Disorders Research, Muscle Physiology and Disorders, Cardiomyopathy and Myosin Studies, RNA modifications and cancer, Epilepsy research and treatment
Most-Cited Works
- → De novo mutations in HCN1 cause early infantile epileptic encephalopathy(2014)234 cited
- → Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome(2018)150 cited
- → Motor and respiratory heterogeneity in Duchenne patients: Implication for clinical trials(2011)138 cited
- → A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy(2017)126 cited
- → Nusinersen in patients older than 7 months with spinal muscular atrophy type 1(2018)120 cited
- → Natural history of Type 2 and 3 spinal muscular atrophy: 2‐year NatHis‐SMA study(2020)111 cited